Loading
Total declarations
Company
▲ Purchases (1 ops.)
▼ Sales (0 ops.)
Latest filing published 16 Jun 2023 for Anika Therapeutics, Inc.. Read the official filing
Filing timeline
BuySaleJeffery S. Thompson
Insider track record
Disclosed buys
1
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Jeffery S. Thompson: trading record in brief
Jeffery S. Thompson (board member) discloses dealings in Anika Therapeutics, Inc. to SEC (Form 4). Over a trading history stretching from 4 February 2016 to 14 June 2023, the count stands at 5 filings.
On the market, this insider has only ever bought: 1 purchase, €45k in total. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Besides market trades, the filings include 4 share grants.
The latest filing, published on 16 June 2023, reports a share grant in Anika Therapeutics, Inc. The last insider purchase was made public on 15 March 2022, 1,678 days ago. Filings reach the SEC (Form 4) feed a median of 4 days after the trade. For comparison, the SEC allows two business days to file a Form 4. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Jeffery S. Thompson
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations5 total
6,500 shares0Common StockSEC:0001171843-23-003962:0
7,954 shares0Common StockSEC:0001171843-22-004297:0
2,000 shares@ US$24.659100.0% of flowCommon StockSEC:0001171843-22-001878:0
Canonical exit: 9 Jun 2022 (T+90)
4,172 shares0Common StockSEC:0001171843-21-004430:0
2,361 sharesCommon StockSEC:0001171843-16-007729:0
5 of 5 declarations
